S

Scribe Therapeutics Inc
D

SCTX

29.600
USD
-0.26
(-0.87%)
مغلق
حجم التداول
7,965
الربح لكل سهم
-10
العائد الربحي
-
P/E
-16
حجم السوق
560,377,728
المقالات
المزيد

العنوان: Scribe Therapeutics Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.